APA (7th ed.) Citation

Haga, S., Nagata, N., Okamura, T., Yamamoto, N., Sata, T., Yamamoto, N., . . . Ishizaka, Y. (2010). TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. Antiviral research, 85(3), 551-555. https://doi.org/10.1016/j.antiviral.2009.12.001

Chicago Style (17th ed.) Citation

Haga, Shiori, Noriyo Nagata, Tadashi Okamura, Norio Yamamoto, Tetsutaro Sata, Naoki Yamamoto, Takehiko Sasazuki, and Yukihito Ishizaka. "TACE Antagonists Blocking ACE2 Shedding Caused by the Spike Protein of SARS-CoV Are Candidate Antiviral Compounds." Antiviral Research 85, no. 3 (2010): 551-555. https://doi.org/10.1016/j.antiviral.2009.12.001.

MLA (9th ed.) Citation

Haga, Shiori, et al. "TACE Antagonists Blocking ACE2 Shedding Caused by the Spike Protein of SARS-CoV Are Candidate Antiviral Compounds." Antiviral Research, vol. 85, no. 3, 2010, pp. 551-555, https://doi.org/10.1016/j.antiviral.2009.12.001.